Cancer phenomics: RET and PTEN as illustrative models (Q28278854)

The DNA sequence and biological annotation of human chromosome

Europe PubMed Central

title

Cancer phenomics: RET and PTEN as illustrative models (English)

0 references

2

Charis Eng

0 references

author name string

Kevin M Zbuk

series ordinal

1

0 references

language of work or name

English

0 references

publication date

January 2007

0 references

published in

Nature Reviews Cancer

0 references

volume

7

0 references

page(s)

35-45

0 references

issue

1

0 references

cites work

1 reference

A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients

31 March 2020

1 reference

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

31 March 2020

1 reference

Protean PTEN: form and function

31 March 2020

1 reference

Genetic aspects of multiple endocrine neoplasia

31 March 2020

1 reference

Will the real Cowden syndrome please stand up: revised diagnostic criteria

31 March 2020

1 reference

Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations

31 March 2020

1 reference

A genotype-phenotype correlation in HNPCC: strong predominance of msh2 mutations in 41 patients with Muir-Torre syndrome

31 March 2020

1 reference

Familial endometrial cancer in female carriers of MSH6 germline mutations

31 March 2020

1 reference

31 March 2020

1 reference

Germline PMS2 mutations: one hit or two?

31 March 2020

1 reference

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

31 March 2020

1 reference

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

31 March 2020

1 reference

Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature

31 March 2020

1 reference

Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia

31 March 2020

1 reference

Expression of the ret proto-oncogene product in human normal and neoplastic tissues of neural crest origin.

31 March 2020

1 reference

Loss of function effect of RET mutations causing Hirschsprung disease.

31 March 2020

1 reference

Mutations of theRET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and Hirschsprung disease

31 March 2020

1 reference

Molecular genetics of multiple endocrine neoplasia types 1 and 2.

31 March 2020

1 reference

Medullary thyroid carcinoma, genes, and the prevention of cancer

31 March 2020

1 reference

Frequent association between MEN 2A and cutaneous lichen amyloidosis

31 March 2020

1 reference

Germ-line mutations in nonsyndromic pheochromocytoma

31 March 2020

1 reference

GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF

31 March 2020

1 reference

RET receptor signaling: dysfunction in thyroid cancer and Hirschsprung's disease.

31 March 2020

1 reference

Characterization of gene expression induced by RET with MEN2A or MEN2B mutation

31 March 2020

1 reference

Genotype-phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium

31 March 2020

1 reference

The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis

31 March 2020

1 reference

A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma

31 March 2020

1 reference

Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC

31 March 2020

1 reference

Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B

31 March 2020

1 reference

Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation

31 March 2020

1 reference

Germline mutation of RET codon 883 in two cases of de novo MEN 2B.

31 March 2020

1 reference

The protein kinase family: conserved features and deduced phylogeny of the catalytic domains

31 March 2020

1 reference

Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations

31 March 2020

1 reference

RET proto-oncogene in the development of human cancer

31 March 2020

1 reference

Seminars in medicine of the Beth Israel Hospital, Boston. The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung's disease

31 March 2020

1 reference

Diverse phenotypes associated with exon 10 mutations of the RET proto-oncogene.

31 March 2020

1 reference

Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease

31 March 2020

1 reference

Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene

31 March 2020

1 reference

PTEN: one gene, many syndromes

31 March 2020

1 reference

The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate

31 March 2020

1 reference

Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN

31 March 2020

1 reference

Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis

31 March 2020

1 reference

Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways

31 March 2020

1 reference

PTEN coordinates G(1) arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model

31 March 2020

1 reference

Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN

31 March 2020

1 reference

Nuclear-cytoplasmic partitioning of phosphatase and tensin homologue deleted on chromosome 10 (PTEN) differentially regulates the cell cycle and apoptosis

31 March 2020

1 reference

Phosphatase and tensin homologue deleted on chromosome 10 (PTEN) has nuclear localization signal-like sequences for nuclear import mediated by major vault protein

31 March 2020

1 reference

Will the real Cowden syndrome please stand up (again)? Expanding mutational and clinical spectra of the PTEN hamartoma tumour syndrome

31 March 2020

1 reference

Germline Inactivation of PTEN and Dysregulation of the Phosphoinositol-3-Kinase/Akt Pathway Cause Human Lhermitte-Duclos Disease in Adults

31 March 2020

1 reference

The Cowden syndrome: a clinical and genetic study in 21 patients

31 March 2020

1 reference

Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation

31 March 2020

1 reference

Germline PTEN mutations in Cowden syndrome-like families.

31 March 2020

1 reference

Novel germline mutations in the PTEN tumour suppressor gene found in women with multiple cancers

31 March 2020

1 reference

Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome

31 March 2020

1 reference

Inherited mutations in PTEN that are associated with breast cancer, cowden disease, and juvenile polyposis

31 March 2020

1 reference

Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease.

31 March 2020

1 reference

Germline mutations in PTEN are present in Bannayan-Zonana syndrome.

31 March 2020

1 reference

Bannayan-Riley-Ruvalcaba syndrome

31 March 2020

1 reference

PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome

31 March 2020

1 reference

Molecular Classification of Patients With Unexplained Hamartomatous and Hyperplastic Polyposis

31 March 2020

1 reference

Contiguous gene deletion within chromosome arm 10q is associated with juvenile polyposis of infancy, reflecting cooperation between the BMPR1A and PTEN tumor-suppressor genes

31 March 2020

1 reference

Deletion of PTEN and BMPR1A on chromosome 10q23 is not always associated with juvenile polyposis of infancy.

31 March 2020

1 reference

Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway

31 March 2020

1 reference

Differential expression of novel naturally occurring splice variants of PTEN and their functional consequences in Cowden syndrome and sporadic breast cancer

31 March 2020

1 reference

Distinct expression profiles for PTEN transcript and its splice variants in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome.

31 March 2020

1 reference

Nuclear localization of PTEN by a Ran-dependent mechanism enhances apoptosis: Involvement of an N-terminal nuclear localization domain and multiple nuclear exclusion motifs

31 March 2020

1 reference

Nuclear PTEN-mediated growth suppression is independent of Akt down-regulation

31 March 2020

1 reference

PTEN: a newly identified regulator of neuronal differentiation

31 March 2020

1 reference

PTEN: from pathology to biology

31 March 2020

1 reference

Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinoma

31 March 2020

1 reference

Prognostic value of codon 918 (ATG-->ACG) RET proto-oncogene mutations in sporadic medullary thyroid carcinoma

31 March 2020

1 reference

Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma

31 March 2020

1 reference

Genetic pathways to glioblastoma: a population-based study

31 March 2020

1 reference

PTEN mutations in endometrial carcinomas: a molecular and clinicopathologic analysis of 38 cases

31 March 2020

1 reference

Lack of PTEN expression in endometrial intraepithelial neoplasia is correlated with cancer progression

31 March 2020

1 reference

RET as a diagnostic and therapeutic target in sporadic and hereditary endocrine tumors

31 March 2020

1 reference

Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis

31 March 2020

1 reference

Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart.

31 March 2020

1 reference

Phase I trial of 72-hour continuous infusion UCN-01 in patients with refractory neoplasms

31 March 2020

1 reference

What Exactly Are Genomes, Genotypes and Phenotypes? And What About Phenomes?

31 March 2020

1 reference

The human phenome project

31 March 2020

1 reference

PROPHECY--a database for high-resolution phenomics

31 March 2020

1 reference

PhenomicDB: a multi-species genotype/phenotype database for comparative phenomics.

31 March 2020

1 reference

"Phenome" project set to pin down subgroups of autism.

31 March 2020

1 reference

Identification of the von Hippel-Lindau disease tumor suppressor gene

31 March 2020

1 reference

Von Recklinghausen neurofibromatosis

31 March 2020

1 reference

Clinical and genetic characteristics of patients with neurofibromatosis type 1 and pheochromocytoma

31 March 2020

1 reference

A role for mitochondrial enzymes in inherited neoplasia and beyond

31 March 2020

1 reference

Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations

31 March 2020

1 reference

A genetic model for colorectal tumorigenesis

31 March 2020

1 reference

Highly penetrant hereditary cancer syndromes.

31 March 2020

1 reference

A serine/threonine kinase gene defective in Peutz-Jeghers syndrome

31 March 2020

1 reference

The LKB1 tumor suppressor negatively regulates mTOR signaling

31 March 2020

1 reference

From developmental disorder to heritable cancer: it's all in the BMP/TGF-beta family

31 March 2020

1 reference

A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4).

31 March 2020

1 reference

Epidermal naevus in Proteus syndrome showing loss of heterozygosity for an inherited PTEN mutation

31 March 2020

1 reference

Cowden disease in a family: A clinical and genetic diagnosis

31 March 2020

1 reference

Concurrence of germline mutations in the APC and PTEN genes in a colonic polyposis family member.

31 March 2020

1 reference

Granular cell tumor in a PHTS patient with a novel germline PTEN mutation

31 March 2020

1 reference

Association between Cowden syndrome and Lhermitte-Duclos disease: report of two cases and review of the literature

31 March 2020

1 reference

Mucocutaneous neuromas: an underrecognized manifestation of PTEN hamartoma-tumor syndrome

31 March 2020

1 reference

Analysis of PTEN gene mutations in Korean patients with Cowden syndrome and polyposis syndrome.

31 March 2020

1 reference

Two novel mutations of PTEN gene in Japanese patients with Cowden syndrome

31 March 2020

1 reference

Cowden's disease: clinical and molecular genetic findings in a patient with a novel PTEN germline mutation

31 March 2020

1 reference

Bannayan-Riley-Ruvalcaba syndrome: further delineation of the phenotype and management of PTEN mutation-positive cases.

31 March 2020

1 reference

Neurofibromatosis type 1 gene as a mutational target in a mismatch repair-deficient cell type.

31 March 2020

1 reference